Navigation Links
Investigators from Children's Hospital LA honored
Date:12/7/2010

LOS ANGELES (December 7, 2010) Three investigators from The Saban Research Institute of Children's Hospital Los Angeles have been elected into the prestigious Society for Pediatric Research. Their election to this Society represents peer recognition of their research achievements in pediatrics.

The Society for Pediatric Research exists to foster the research and career development of investigators engaged in creating new knowledge that advances the health and well‐being of young people. Membership is by election only.

Steven Mittelman, MD, PhD, conducts his research at the Center for Endocrinology, Diabetes and Metabolism at Children's Hospital Los Angeles, and is an assistant professor of Pediatrics, Physiology, and Biophysics at the Keck School of Medicine of the University of Southern California.

"Being overweight impairs our ability to treat a patient's leukemia, the most common cancer occurring in children," explains Dr. Mittelman. "We've found that fat cells secrete chemical messengers that cause leukemia cells to migrate into the fat. Fat cells also secrete factors that protect leukemia cells from chemotherapy, making the disease more difficult to treat."

Leo Mascarenhas, MD, MS, is director of the Clinical Trials Office in the Children's Center for Cancer and Blood Diseases and Principal Investigator for the National Cancer Institute funded Children's Oncology Group grant at Children's Hospital Los Angeles. He is an associate professor of Clinical Pediatrics at the Keck School of Medicine of the University of Southern California.

"Childhood cancer is the leading cause of disease-related death in pediatrics in the United States," says Dr. Mascarenhas whose research focuses on developmental therapeutics for patients with bone and soft tissue sarcomas. "Despite the remarkable progress made in the treatment of childhood cancer in the last four decades, improved therapies are still needed for our patients with a poor prognosis and less toxic therapies for those destined to survive. This can be accomplished only through basic, translational and clinical research."

The lab overseen by Sebastien Bouret, PhD, is part of the Neuroscience program at The Saban Research Institute of Children's Hospital. He is an assistant professor of Pediatrics at the Keck School of Medicine of the University of Southern California.

"One theory explaining obesity is called perinatal programming," said Dr. Bouret. "Perinatal programming refers to the effect of specific events, that occur during gestation and soon after birth, on lifelong health. Nutrition during pregnancy appears to have an important impact on obesity, with both maternal obesity and maternal malnutrition increasing the incidence of obesity and type 2 diabetes in babies born to these mothers."

Dr. Brent Polk, director of The Saban Research Institute and chair of the Department of Pediatrics said, "On behalf of the Department of Pediatrics and The Saban Research Institute, I congratulate Drs. Mittelman, Mascarenhas and Bouret on this important recognition of their respective contributions to pediatric oncology and obesity, two devastating conditions affecting children today. Their acknowledgement, by membership in the Society for Pediatric Research, also underlines the quality of overall research we are doing in pediatrics at Children's Hospital Los Angeles and at the Keck School of Medicine of the University of Southern California."


'/>"/>

Contact: Ellin Kavanagh
ekavanagh@chla.usc.edu
323-361-8505
Children's Hospital Los Angeles
Source:Eurekalert

Related medicine news :

1. Investigators examine colorectal cancer screening methods among diverse populations
2. UT Southwestern investigators perform head-to-head comparison of incontinence treatments
3. Damon Runyon Cancer Research Foundation awards $3.1M to 8 top young clinical investigators
4. Investigators identify gene associated with kidney disease in African-American population
5. SWOG names 5 cancer researchers outstanding Young Investigators
6. NCH investigators receive grant to distinguish bacterial infections from viral infections in infants
7. Parents Want Electronic Access to Their Childrens Docs: Survey
8. Researcher at Childrens Hospital LA discovers way to overcome radiation resistance in leukemia
9. The private sale of drugs in public hospitals
10. Minnesota Department of Health Report: Nearly 6,000 Hospitalizations for COPD in 2007
11. Bariatricfurnishings.com Launches Unique Eco-friendly Seating for Health Care, Hospitality, Assisted Living Centers, and Home Use at Competitive Prices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... ... companies, has achieved ISO 17100:2015 certification following a comprehensive audit performed by ... globally recognized standard that establishes guidance for critical processes within translation, quality ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... the highly acclaimed series, Innovations with Ed Begley, Jr., scheduled to broadcast Saturday, ... technology behind SmartCap, which was founded in 2008 to address the limitations of ...
(Date:1/23/2017)... FL (PRWEB) , ... January 23, 2017 , ... Wooden and plastic balance boards have ... strength and improve balance. Kumo Board is the first and only balance board ... it to be soft and rigid at the same time as well as skill-level adjustable ...
(Date:1/23/2017)... ... January 23, 2017 , ... Sharon Kleyne, America’s leading water researcher, advocate ... about the benefits of making new water infrastructure a number one priority. “As we ... we expect water infrastructure to become a top priority of our new political change ...
(Date:1/23/2017)... ... 23, 2017 , ... Zachary Cattell, President of the Indiana ... industry expert at the 2017 Sector Summit hosted by Ivy Tech Community College ... Gerry Dick, will feature an employer and an association representative from five of ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... January 23, 2017 Varias ... enal) y el riesgo de ... a pabetalone    Resverlogix Corp. ("Resverlogix" ... preliminares de un ensayo en fase 1 con sede ... riñón (renal) severa. Los datos demostraron unos resultados importantes ...
(Date:1/23/2017)... January 23, 2017 Longer life expectancy and rising ... global market for medical device technologies. BCC Research reveals in ... Asia-Pacific region, should see strong growth due to rising ... incomes. Continue Reading ... ...
(Date:1/23/2017)... PALMA, Spain , January 23, ... a clinical-stage biopharmaceutical company focused on treatments for ... has been enrolled in the Phase IIb "CaLIPSO ... the treatment of cardiovascular calcification (CVC) in end-stage-renal-disease ... ESRD patients, in the last stage of chronic ...
Breaking Medicine Technology: